UK hospital to check embryos for colon cancer risk

Key points
- Couples who have a risk of passing on an inherited form of colon cancer to their children will be allowed to have their embryos screened to ensure they do not carry the faulty gene that causes the illness.
- The Human Fertilisation and Embryology Authority (HFEA), the country's fertility watchdog, said it granted a license to University College Hospital in London to screen for familial adenomatous polyposis (FAP), a cancer that usually occurs in children in their early teens.
- "At the moment we have issued a license to one hospital, University College Hospital," a spokesperson for the HFEA said in an interview.
- Fertility clinics in Britain can already screen embryos created through in-vitro fertilization (IVF) for diseases such as cystic fibrosis and Huntington's disease.
Couples who have a risk of passing on an inherited form of colon cancer to their children will be allowed to have their embryos screened to ensure they do not carry the faulty gene that causes the illness.
The Human Fertilisation and Embryology Authority (HFEA), the country's fertility watchdog, said it granted a license to University College Hospital in London to screen for familial adenomatous polyposis (FAP), a cancer that usually occurs in children in their early teens.
"At the moment we have issued a license to one hospital, University College Hospital," a spokesperson for the HFEA said in an interview.
Fertility clinics in Britain can already screen embryos created through in-vitro fertilization (IVF) for diseases such as cystic fibrosis and Huntington's disease. The new license is the first for an inherited form of cancer.
It will enable the hospital to screen embryos and ensure that only those free of the faulty gene are transferred to the womb.
"We are overjoyed to have been given this chance, not only to do as much as possible to make sure our children don't have this gene, but to stop them passing it on," one of the patients who will benefit from the decision, told The Times newspaper.
Critics fear the decision will lead to doctors being able to pick and choose other diseases and apply for permission to screen embryos for them.
But Vishnee Seenundun of the HFEA said any clinic that wants to carry out pre-implantation genetic diagnosis (PGD) must obtain a license from the HFEA.
"The HFEA issues licenses for PGD where the embryo is at significant risk of developing a serious condition," the authority said.
"All PGD applications are sent out to a minimum of two peer reviewers and decisions are taken by HFEA license committees who consider the scientific, ethical and medical information."
FAP is an inherited condition caused by mutations in the adenomatous polyposis coli (APC) gene. Half of children of a parent with the mutated gene, which leads to the development of polyps in the colon which can turn into cancer, will inherit it.
Using PGD, doctors can genetically analyze a single cell from an embryo to determine whether it has the faulty gene.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsColon cancer screening guidelines may miss 10 percent of colon cancers
For people with a family history of adenomas (colon polyps that lead to colon cancer), up to 10 percent of colorectal cancers could be missed when current national screening guidelines are followed. Colorectal cancer is…
23 October 2013
NewsMinimally invasive operation helps elderly patients after colon cancer treatment
The chance of ending up in a nursing facility appears to be significantly lower for older patients who undergo a laparoscopic procedure than for those who have open surgical resection for colon cancer, according to a…
9 October 2013
NewsStudies confirm colon cancer screening reduces deaths
There's new evidence that regular screening for colon cancer has long-term benefits. Testing for blood in the stool reduced the risk of death from colorectal cancer by as much as 32 percent and it seemed to keep the…




